Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: Efficacy and long-term safety

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 892-894

  Esposito, L ^a   Kamar, N ^a,b   Durand, D ^a   Rostaing, L ^a  

^a CHU RANGUEIL   (France)

^b TSA 50032 ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; STEROID; THYMOCYTE ANTIBODY;

CELL COUNT; CLINICAL TRIAL; CONFERENCE PAPER; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; GENE TARGETING; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; SIDE EFFECT; T LYMPHOCYTE;

EID: 17844372250     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.267     Document Type: Conference Paper

References (4)

1. P. Ljungman Workshop of CMV disease definitions, clinical severity scores and new syndromes Scand J Infect Dis 99 suppl 1995 87
2. K.L. Hardinger, M.A. Schnitzler, B. Miller Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation Transplantation 78 2004 136
3. A. Djamali, C. Turc-Baron, P. Portales Low dose anithymocyte globulins in renal transplantation: Daily versus intermittent administration based on T-cell monitoring Transplantation 69 2000 799
4. I. Agha, J. Rueda, A. Alvarez Short course induction immunosuppression with Thymoglobulin for renal transplant recipients Transplantation 73 2002 473